Healthcare provider profile · identity verified

Carly Worden, NP

Nurse Practitioner · KENOSHA, WI · NPI 1053926949

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	338	110
Atorvastatin Calcium	Atorvastatin Calcium	301	87
Lisinopril	Lisinopril	279	83
Pantoprazole Sodium	Pantoprazole Sodium	179	50
Gabapentin	Gabapentin	178	59
Losartan Potassium	Losartan Potassium	170	54
Levothyroxine Sodium	Levothyroxine Sodium	163	51
Metoprolol Succinate	Metoprolol Succinate	153	42
Metformin Hcl	Metformin Hcl	126	44
Alprazolam	Alprazolam	115	38
Ozempic	Semaglutide	115	23
Valsartan	Valsartan	105	34
Hydrochlorothiazide	Hydrochlorothiazide	96	30
Jardiance	Empagliflozin	94	28
Rosuvastatin Calcium	Rosuvastatin Calcium	89	27
Simvastatin	Simvastatin	89	27
Potassium Chloride	Potassium Chloride	76	23
Warfarin Sodium	Warfarin Sodium	74	22
Furosemide	Furosemide	73	29
Omeprazole	Omeprazole	73	26
Pravastatin Sodium	Pravastatin Sodium	73	25
Clopidogrel	Clopidogrel Bisulfate	69	20
Metoprolol Tartrate	Metoprolol Tartrate	68	22
Trazodone Hcl	Trazodone Hcl	65	18
Albuterol Sulfate Hfa	Albuterol Sulfate	61	25
Fluticasone Propionate	Fluticasone Propionate	61	21
Metformin Hcl Er	Metformin Hcl	60	22
Zolpidem Tartrate	Zolpidem Tartrate	57	20
Tamsulosin Hcl	Tamsulosin Hcl	52	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	16
Citalopram Hbr	Citalopram Hydrobromide	43	11
Meloxicam	Meloxicam	43	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	32
Glipizide	Glipizide	39	14
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Cefadroxil	Cefadroxil	37	32
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Ezetimibe	Ezetimibe	37	16
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Carvedilol	Carvedilol	36	12
Famotidine	Famotidine	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	13
Prednisone	Prednisone	33	31
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Atenolol	Atenolol	31	11
Tramadol Hcl	Tramadol Hcl	31	11
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Trulicity	Dulaglutide	29	12
Calcitonin-Salmon	Calcitonin,salmon,synthetic	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Linzess	Linaclotide	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Nystatin	Nystatin	28	16
Sertraline Hcl	Sertraline Hcl	28	12
Enalapril Maleate	Enalapril Maleate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Arnuity Ellipta	Fluticasone Furoate	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Eliquis	Apixaban	25	suppressed
Digoxin	Digoxin	24	suppressed
Fluconazole	Fluconazole	24	17
Ibuprofen	Ibuprofen	24	suppressed
Xarelto	Rivaroxaban	24	11
Nifedipine Er	Nifedipine	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Baclofen	Baclofen	17	suppressed
Cefdinir	Cefdinir	17	16
Finasteride	Finasteride	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Mounjaro	Tirzepatide	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Klor-Con	Potassium Chloride	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Cephalexin	Cephalexin	13	11
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Diazepam	Diazepam	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error